BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...
Amneal Pharmaceuticals Inc, a global biopharmaceutical company headquartered in Bridgewater, announced that the US Food and Drug Administration (FDA) has tentatively approved the company’s Abbreviated ...
Company’s first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines segment BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback